C. Chaib

621 total citations
16 papers, 430 citations indexed

About

C. Chaib is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, C. Chaib has authored 16 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Surgery. Recurrent topics in C. Chaib's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Lung Cancer Research Studies (5 papers). C. Chaib is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Lung Cancer Research Studies (5 papers). C. Chaib collaborates with scholars based in United Kingdom, United States and Belgium. C. Chaib's co-authors include Juan Luis Gomez Marti, Cinta Pallarés, H. Cortés-Funes, Joan Carles, Ricardo Hitt, Antonio Antón, Miguel A. Sánchez, Dolores Isla, Javier Martínez‐Trufero and Francisco S. N. Lobo and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Quality of Life Research.

In The Last Decade

C. Chaib

16 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Chaib United Kingdom 7 282 222 204 180 38 16 430
T. Nwizu United States 11 276 1.0× 167 0.8× 109 0.5× 140 0.8× 41 1.1× 23 340
Edvard Abel Sweden 8 128 0.5× 75 0.3× 105 0.5× 115 0.6× 34 0.9× 13 236
Grant Creaney United Kingdom 3 177 0.6× 58 0.3× 107 0.5× 84 0.5× 72 1.9× 3 354
Gopal Bajaj United States 11 157 0.6× 129 0.6× 88 0.4× 127 0.7× 24 0.6× 21 286
Luciana Lastrucci Italy 9 250 0.9× 131 0.6× 111 0.5× 179 1.0× 38 1.0× 12 344
Ljiljana Tadić Serbia 6 418 1.5× 302 1.4× 172 0.8× 222 1.2× 36 0.9× 13 495
Martin Robinson United Kingdom 3 306 1.1× 190 0.9× 99 0.5× 127 0.7× 19 0.5× 4 436
Charissa Goh Singapore 5 273 1.0× 196 0.9× 124 0.6× 102 0.6× 14 0.4× 14 325
Saori Wendy Herman United States 10 128 0.5× 152 0.7× 162 0.8× 57 0.3× 62 1.6× 18 333
Xiaowei Shen Canada 6 337 1.2× 226 1.0× 188 0.9× 108 0.6× 54 1.4× 10 472

Countries citing papers authored by C. Chaib

Since Specialization
Citations

This map shows the geographic impact of C. Chaib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Chaib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Chaib more than expected).

Fields of papers citing papers by C. Chaib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Chaib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Chaib. The network helps show where C. Chaib may publish in the future.

Co-authorship network of co-authors of C. Chaib

This figure shows the co-authorship network connecting the top 25 collaborators of C. Chaib. A scholar is included among the top collaborators of C. Chaib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Chaib. C. Chaib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Provencio, Mariano, Enric Carcereny, Rafael López Castro, et al.. (2023). Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study. Translational Lung Cancer Research. 12(10). 2113–2128. 7 indexed citations
2.
3.
4.
Soares, Marta, Luís Antunes, Patrícia Redondo, et al.. (2021). Treatment and outcomes for early non-small-cell lung cancer: a retrospective analysis of a Portuguese hospital database. PubMed. 10(2). LMT46–LMT46. 9 indexed citations
5.
Soares, Marta, Luís Antunes, Patrícia Redondo, et al.. (2021). Small cell lung cancer treatment and survival in Portugal: A retrospective analysis from the I‐O Optimise initiative. European Journal of Cancer Care. 30(6). e13496–e13496. 5 indexed citations
6.
Soares, Marta, Luís Antunes, Patrícia Redondo, et al.. (2020). Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative. BMC Pulmonary Medicine. 20(1). 240–240. 20 indexed citations
7.
Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2019). P2.12-01 Small Cell Lung Cancer (SCLC) Treatment and Survival in the UK: A REAL-Oncology Analysis from the I-O Optimise Initiative. Journal of Thoracic Oncology. 14(10). S812–S812. 1 indexed citations
8.
Wood, Robert, Gavin Taylor‐Stokes, Fiona Smith, & C. Chaib. (2019). The humanistic burden of advanced non-small cell lung cancer (NSCLC) in Europe: a real-world survey linking patient clinical factors to patient and caregiver burden. Quality of Life Research. 28(7). 1849–1861. 31 indexed citations
9.
Soares, Marta, Luís Antunes, Patrícia Redondo, et al.. (2019). Treatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative. Annals of Oncology. 30. ii15–ii16. 1 indexed citations
10.
Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2019). Temporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative. Annals of Oncology. 30. ii14–ii15. 1 indexed citations
11.
12.
Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2018). P2.01-91 Treatment Patterns in Patients with Stage IIIB-IV NSCLC in Clinical Practice: Retrospective Analysis of a UK Trust Database. Journal of Thoracic Oncology. 13(10). S700–S700. 4 indexed citations
13.
Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2018). P82 Treatment patterns in patients with stage IIIB-IV NSCLC in clinical practice: retrospective analysis of a UK trust database. A145.2–A146. 2 indexed citations
14.
15.
Hitt, Ricardo, Antonio López–Pousa, Javier Martínez‐Trufero, et al.. (2005). Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer. Journal of Clinical Oncology. 23(34). 8636–8645. 319 indexed citations
16.
Massutí, Bartomeu, Carlos Camps, Ramón Barceló, et al.. (2004). Weekly paclitaxel (PCT) in non-small cell lung cancer (NSCLC): Results in older or frail patients. A Spanish Lung Cancer Group Trial (GECP 00-02). Journal of Clinical Oncology. 22(14_suppl). 8044–8044. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Nwizu Breakdown of academic impact, for papers by Edvard Abel Breakdown of academic impact, for papers by Grant Creaney Breakdown of academic impact, for papers by Gopal Bajaj Breakdown of academic impact, for papers by Luciana Lastrucci Breakdown of academic impact, for papers by Ljiljana Tadić Breakdown of academic impact, for papers by Martin Robinson Breakdown of academic impact, for papers by Charissa Goh Breakdown of academic impact, for papers by Saori Wendy Herman Breakdown of academic impact, for papers by Xiaowei Shen
Rankless by CCL
2026